Hepatic and skin metastases after laparoscopic radical prostatectomy for prostate cancer

Journal of Gastrointestinal and Liver Diseases

Volumn 16, Issue 3, 2007, Pages 333-335

  Coman, Ioan ^a   Cri̧an, Nicolae ^a   Petruţ, Bogdan ^a   Bungǎrdean, Cǎtǎlina ^b   Cristea, Tudor ^a   Crişan, Dana ^c  

^a Department of Urology ^*  (Romania)

^b Municipal Clinical Hospital   (Romania)

^c IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Atypical metastases; Hepatic metastases; Prostate cancer; Trocar site metastases

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BICALUTAMIDE; BILIRUBIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DIGITAL RECTAL EXAMINATION; ECHOGRAPHY; GASTRIC BANDING; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER METASTASIS; MALE; PROSTATE CANCER; PROSTATECTOMY; SKIN METASTASIS; SYMPTOM; TRANSURETHRAL RESECTION; TROCAR; URINE RETENTION;

ADENOCARCINOMA; CARCINOMA IN SITU; FOLLOW-UP STUDIES; HUMANS; LAPAROSCOPY; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE; PROSTATIC NEOPLASMS; SKIN NEOPLASMS; SURGICAL INSTRUMENTS; TIME FACTORS; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 34948904854     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 1997;33:1075-1107.
2. Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002;38:99-166.
3. nd update ed. Cluj-Napoca: "Iuliu Haţieganu" Medical University Publishing 2005: 175-194.
4. Lange PH. Prognostic factors and clinical significance of cancers detected by screening: growth rate and progression of prostate cancer. J Urol 1994;152(5 Pt 2):1707-1708.
5. Mansfield JT, Stephenson RA. Does transurethral resection of the prostate compromise the radical treatment of prostate cancer? Semin Urol Oncol 1996; 14:174-177.
6. Meacham RB, Scardino PT, Hoffman GS, Easley JD, Wilbanks JH, Carlton CE. The risk of distant metastases after transurethral resection of the prostate versus needle biopsy in patients with localized prostate cancer. J Urol 1989; 142(2 Pt 1):320-325.
7. Ramon J, Rossignol G, Leandri P, Gautier JR. Morbidity of radical retropubic prostatectomy following previous prostate resection. J Surg Oncol 1994; 55: 14-19.
8. Schurholz T, Schulze H, Finke W, Lange S, Senge T. Clinical relevance of incidental prostate carcinoma. A retrospective study. Urologe A 1996; 35: 315-320.
9. Manseck A, Wirth M, Theiss M, Frohmuller H. Radical prostatectomy in patients with incidental prostate carcinoma. Urol Int 1994; 53: 196-208.
10. Bandhauer K, Senn E. Radical retropubic prostatectomy after transurethral prostatic resection. Eur Urol 1988; 15: 180-181.
11. Birtle AJ, Freeman A, Masters JR, Payne HA, Harland SJ; BAUS Section of Oncology Cancer Registry. Clinical features of patients who present with metastatic prostate carcinoma and serum prostate-specific antigen (PSA) levels < 10 ng/mL: the "PSA negative" patients. Cancer 2003; 98: 2362-2367.
12. Long MA, Husband JE. Features of unusual metastases from prostate cancer. Br J Radiol 1999; 72: 933-941.
13. Bubendorf L, Schopfer A, Wagner U, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 2000; 31: 578-583.